Is it safe to take nalidixic acid for curing urinary infection in pregnancy? (5.5 months)?

Answers (1)

21 Apr 2011

Nalidixic acid has been assigned to pregnancy category C by the FDA. Animal studies have revealed teratogenic and embryocidal effects and prolonged pregnancy duration. There are no controlled data in human pregnancy. No birth defects were reported in 63 newborns whose mothers had taken the drug during pregnancy. Cartilage damage and arthropathy are reported in immature animals giving rise to concern over effects on bone formation in the developing fetus. Because safer alternatives are available, some experts consider quinolones contraindicated during pregnancy, especially during the first trimester. Nalidixic acid is only recommended for use during pregnancy when benefit outweighs risk.

However, please do talk with your gynecologist before you start to take the med.

Take care, & wish your baby all the best!

Votes: +0

Search for questions

Still looking for answers? Try searching for what you seek or ask your own question.

Similar questions

Is it safe to take Amoxicillin 500mg 3 times daily during pregnancy?

Hi, I have been diagnosed with a urinary infection whilst 24 weeks pregnant. The GP prescribed one 500mg capsule of Amoxicillin 3 times daily - im ...

2 answers 23 Aug 2010

Is ciprofloxacin 750mg that is used for vet use safe for humans?

My friend has a UTI & is taking cipro 750mg that was prescribed to her dog for a bacterial infection... is this safe?

1 answer 10 Jul 2011

Urinary Tract Infection - I just noticed a small pimple on my vagina.Maybe about 1/2 the size of a?

... pea.Any ideas on what this could be from & if it will go away. I was washing & i felt it there.thanks for any answers

3 answers 29 Apr 2012

My 8yr old daughter was prescribed nitrofurantoin (1tsp at dinner each night) to hold off urinary?

... tract infections. She was diagnosed with stage 3 vesicoureteral reflux and is having surgery next month using the Deflux injection method to ...

1 answer 11 days ago

Further Information